MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 229 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,550 | -50.2% | 24,155 | -38.1% | 1.43% | +115.7% |
| Q2 2023 | $485,155 | +11.8% | 39,031 | +26.0% | 0.66% | +258.9% |
| Q1 2023 | $433,876 | +9.5% | 30,969 | +11.9% | 0.18% | +3.4% |
| Q4 2022 | $396,187 | +30.3% | 27,686 | +132.5% | 0.18% | -17.1% |
| Q3 2022 | $304,000 | +35.1% | 11,907 | +50.1% | 0.22% | +129.8% |
| Q2 2022 | $225,000 | -34.2% | 7,935 | -18.2% | 0.09% | -46.3% |
| Q1 2022 | $342,000 | -50.6% | 9,695 | -41.4% | 0.18% | -74.1% |
| Q4 2021 | $693,000 | -50.6% | 16,551 | -42.1% | 0.68% | -25.6% |
| Q3 2021 | $1,402,000 | – | 28,569 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |